An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

991

Participants

Timeline

Start Date

May 28, 2012

Primary Completion Date

February 10, 2016

Study Completion Date

February 10, 2016

Conditions
Hepatitis C, Chronic
Trial Locations (21)

13110

Rebecca Sieff Medical Center; Liver Unit, Safed

18101

Haemek Hospital; Gastroenterology, Afula

22100

Western Galilee Hospital - Nahariya, Nahariya

31096

Rambam Medical Center; Gastroenterology - Liver Unit, Haifa

33394

Bnei-Zion Medical Center; Gastroenterology, Haifa

34362

Carmel Hospital; Liver Unit, Haifa

38100

Hillel Yaffe Hospital; Gastroenterology, Hadera

44281

Meir Medical Center; Liver Unit, Kfar Saba

58100

Wolfson Hospital; Gastroenterology Unit, Holon

76100

Kaplan Medical Center; Gastroenterology Unit, Rehovot

78278

Barzilai MC; Gastroenterology, Ashkelon

84105

Soroka Medical Center; Gastroenterology, Beersheba

91031

Shaare Zedek Hospital Liver Unit; Liver Unit, Jerusalem

91120

Hadassah Hospital; Liver Unit, Jerusalem

5262100

Sheba Medical Center; Tel Hashomer, Ramat Gan

6093000

Assaf Harofeh; Gastroenterology, Ẕerifin

6423906

Tel-Aviv Sourasky Medical Center; Liver Unit, Tel Aviv

Unknown

Holy Family Medical Center; Liver Unit, Nazareth

Beilinson-Rabin Liver Unit; Liver Unit, Petah Tikva

Hasharon Mc; Gastroenterology, Petah Tikva

Poria Hospital; Gastroenterology, Tiberias

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Clalit Health Services

OTHER

lead

Hoffmann-La Roche

INDUSTRY